Emerging paradigms in applied bioinformatics

Drug Discovery Today: BIOSILICO

Volumn 1, Issue 3, 2003, Pages 86-88

  Ilyin, Sergey E ^a   Pinhasov, Albert ^a   Vaidya, Anil H ^a   Amato, Frank A ^a   Kauffman, Jack ^a   Xin, Hong ^a   Andrade Gordon, Patricia ^a   Plata Salamán, Carlos R ^a   Brenneman, Douglas E ^a  

^a Johnson Johnson P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; DNA; MESSENGER RNA; RNA;

BIOINFORMATICS; DNA MICROARRAY; DRUG INDUSTRY; GENE EXPRESSION; GENE SILENCING; NONHUMAN; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA INTERFERENCE; SHORT SURVEY; VALIDATION PROCESS;

EID: 3343017996     PISSN: 17418364     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1478-5382(03)02315-1     Document Type: Short Survey

References (22)

1. Lathia, C.D. (2002) Biomarkers and surrogate endpoints: how and when might they impact drug development? Disease Markers 18, 83-90
2. Wagner, J.A. (2002) Overview of biomarkers and surrogate endpoints in drug development. Disease Markers 18, 41-46
3. Otvos, J.D. et al. (2002) Measurement issues related to lipoprotein heterogeneity. Am. J. Cardiol. 90, 22i-29i
4. Saves, M. et al. (2001) Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy. Clin. Immunol. 99, 347-352
5. Darrow, A.L. et al. (2003) Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening. J. Biomol. Screening 8, 65-71
6. Yamaguchi, S. and Nakanishi, S. (1998) Regional expression and regulation of alternative forms of mRNAs derived from two distinct transcription initiation sites of the rat mGluRS gene. J. Neurochem. 71, 60-68
7. Ilyin, S.E. et al. (1998) Modifications of RNase protection assay for neuroscience applications. J. Neurosci. Methods 84, 139-141
8. Gozes, I. et al. (1989) Lactation elevates vasoactive intestinal peptide messenger ribonucleic acid in rat suprachiasmatic nucleus. Endocrinology 124, 181-186
9. Heid, C.A. et al. (1996) Real time quantitative PCR. Genome Res. 6, 986-994
10. Lang, R. et al. (1997) A rapid method for semiquantitative analysis of the human Vβ-repertoire using TaqManR PCR. J. Immunol. Methods 203, 181-192
11. Lie, Y.S. and Petropoulos, C.J. (1998) Advances in quantitative PCR technology: 5 nuclease assays. Curr. Opin. Biotechnol. 9, 43-48
12. Medhurst, A.D. et al. (2000) The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J. Neurosci. Methods 98, 9-20
13. Schena, M. et al. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-170
14. DeRisi, J. et al. (1996) Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457-160
15. Noordewier, M.O. and Warren, P.V. (2001) Gene expression microarrays and the integration of biological knowledge. Trends Biotechnol. 19, 412-415
16. Barlow, C. and Lockhart, D.J. (2002) DNA arrays and neurobiology - what's new and what's next? Curr. Opin. Neurobiol. 12, 554-561
17. Dean, N.M. (2001) Functional genomics and target validation approaches using antisense oligonucleotide technology. Curr. Opin. Biotechnol. 12, 622-625
18. Fjose, A. et al. (2001) RNA interference: mechanisms and applications. Biotechnol. Annu. Rev. 7, 31-57
19. Elbashir, S.M. et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498
20. Harborth, J. et al. (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114, 4557-1565
21. Elbashir, S.M. et al. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213
22. McCaffrey, A.P. et al. (2002) RNA interference in adult mice. Nature 418, 38-39